Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigation of the Safety and Efficacy of Oral AKL1 in Patients Diagnosed With Obstructive Lung Disease

NCT00920127 is registered in ClinicalTrials.gov with University of East Anglia as lead sponsor.

NCT NCT00920127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00920127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigation of the Safety and Efficacy of Oral AKL1 in Patients Diagnosed With Obstructive Lung Disease
Lead sponsor
University of East Anglia
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 30, 2009
Completion date
February 29, 2012
Enrollment
164 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic obstructive pulmonary disease, obstructive lung disease